Chandler Capital

Chandler Capital

Expertise: Technology, Pharmaceutical, Energy, GARP

Chandler Capital is the work of Ian Hartana and Vayun Chugh.

Ian Hartana is a self-taught investor whose work has been featured on Seeking Alpha under the organization AlmaStreet Capital. Being on the student advisory board of the Young Investors Society, he is a long-time advocate for the advancement of financial literacy and has competed on the international level in multiple competitions. In his free time, he enjoys exploring the intersection between behavioral science and economics through writing on the platform Medium and is currently working as an intern at a small venture capital firm.

Vayun Chugh is also a self-taught investor and is both an editor and writer for AlmaStreet Capital. He is the president of his school’s finance club alongside Ian Hartana, and has also competed in multiple international competitions. Through his ongoing research in the medical field, Vayun has developed a deep understanding of the pharmaceutical industry and knows the characteristics of an undervalued company.

Ian and Vayun’s expertise lies in finding value in undervalued companies in the tech, pharmaceutical, and energy sectors which have the potential for growth at a reasonable price. They have a long-term investment horizon and consider ESG as an increasingly important factor in their research process.

Recent Articles

The 3 Best ESG Stocks to Buy in January 2024

These three ESG stocks have great planet-conscious metrics and a promising earnings outlook. Consider adding them to your buy list now.

Why These 3 Semiconductor Stocks Should Be on Your Radar in 2024

The stock market has been performing well recently, with the S&P 500 rallying up over 4% in the last month. However, with investors always looking…

3 Sleeper Stocks You’ll Regret Not Buying Soon: December Edition

Investors should look at these three undervalued sleeper stocks in December to boost and fortify their financial portfolios.

3 Biotech Stocks With Promising Pipelines and Big Growth Potential in 2024

These biotech stocks with promising pipelines are showing some major promise and growth potential for the new year.

The 3 Most Undervalued Renewable Energy Stocks to Buy in December

Investors keep these three undervalued renewable energy stocks on their radar as they head into the holiday season.